Comparative evaluation of genotyping and low-pass sequencing for pharmacogenetic variant and phenotype inference
Overall, LP-WGS provides broader variant coverage and improved resolution for selected pharmacogenes but did not resolve all clinically important loci, and these findings support further evaluation of LP-WGS as a scalable PGx screening approach, especially where long-term genomic data reuse is a priority.